This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Compare rebalancing frequency between index funds and target-date funds and what that means for risk, fees, and long-term performance. A quick look at when to expect adjustments.
28,361 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Healthcare sector ETFs offer defense and income, but not all are created equal. This article dives into how state str...
Three distinct humanoid robotics ETFs now offer investors a way to ride the AI-enabled automation surge, each with a ...
Goldman Sachs and KeyBanc boosted AT&T price targets after the telecom giant unveiled a three-segment reporting model...
Looking for the best-performing tech stocks this week? This guide breaks down how to spot momentum, what to watch, an...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
In a markets backdrop marked by higher rates and sector stresses, SRET continues to pay monthly distributions, unders...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
Dubai's property market is cooling as buyers pull back and prices fall. Analysts weigh whether the dip is a temporary...
Optics stocks rally as AI infrastructure demand returns, led by Applied Optoelectronics with notable moves in LUMENTU...
June brought a notable move in the tech pocket as D-Wave Quantum jumped after a price-target boost from Mizuho. This ...
A 40-year-old, freshly divorced, earns $85,000 with no savings. Financial planners say a disciplined plan could reach...